Cytokines mediated inflammation and decreased neurogenesis in animal models of depression.
about
Psychogenic fever: how psychological stress affects body temperature in the clinical populationAre Anxiety Disorders Associated with Accelerated Aging? A Focus on NeuroprogressionNeuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA DysregulationHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbidityDepression and sickness behavior are Janus-faced responses to shared inflammatory pathways.Association among stress, salivary cortisol levels, and chronic periodontitisRodent models of depression: neurotrophic and neuroinflammatory biomarkers.Early life environment and developmental immunotoxicity in inflammatory dysfunction and diseaseAssociation of Periodontitis and Subsequent Depression: A Nationwide Population-Based StudyComments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67.The behavioral and immunological impact of maternal separation: a matter of timingcAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress.Dysbiosis of the gut microbiota in disease.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Targeting the neurovascular unit for treatment of neurological disorders.Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy.Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study.Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxietyEffects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease.Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression.Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice.The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling.Candidate Risks Indicators for Bipolar Disorder: Early Intervention Opportunities in High-Risk Youth.Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus.Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancerDuality of Antidepressants and Neuroprotectants.Low Serum Levels of Uric Acid are Associated With Development of Poststroke Depression.Neuroinflammation, neurodegeneration, and depression.Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?Peripheral biomarkers in animal models of major depressive disorder.Effects of diabetes on hippocampal neurogenesis: links to cognition and depression.Intake of Mediterranean foods associated with positive affect and low negative affect.Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.Targeting IL-1 in depression.
P2860
Q26745791-BFD4056B-D0C8-4E36-985E-DF6ABFC804BDQ26765559-04727AE2-4482-46BF-8136-812D01F170DCQ26770754-D87C6EF7-CC29-44CB-965F-2ECFCCD82394Q26784030-A07E0556-E0C7-4E89-B220-0878A0DEC266Q26823313-C2918587-4CCF-42A5-ADA5-EC12AC432A16Q28382882-2E04CFC2-F5F5-4B65-A21B-E9C268D81652Q28388439-C29E2E06-C1A4-4A5D-8F1D-D81CAD4BB0A4Q28397459-4C98C3AE-3BE2-46C0-8A48-6E9A5303DB5AQ28397981-D66438ED-3BB6-42EF-A7B3-14462E530770Q31121789-0CEEC6BE-C6B3-4587-A86C-A6EC666CBCFEQ33659663-ACB09E8E-A838-49B0-8649-E4BB82718232Q33829223-B64C8996-AF36-477E-97A3-B80C748EC2F0Q34461294-B0C179B4-9971-4530-84AD-2AC094174D75Q34898890-6F549755-403E-45A5-8D3F-AA5F9C954B31Q34974827-236B3307-6027-4203-B3EE-16C87CD987B6Q35064192-99A3093F-2E09-4550-AE70-A6685F7D0CCBQ35118685-4AD280A4-8CB3-469D-BD04-98F8842E7BB3Q35158376-FD35A217-384D-43BC-BD4D-1B36EFD0FFD5Q35460864-4615DCD7-CFE1-442F-8C33-2400CD9D39F7Q36067322-909C0C16-F815-4423-800E-A16FD4A915A3Q36090823-3DE3E893-9178-48DE-890E-2158D02A9105Q36156604-464F2E45-1C27-456A-95E6-3075691DB540Q36327782-7D2457BB-196E-4F62-AE74-789CD2809A20Q36488674-2361BBCF-9250-48C2-86C1-C6225CDB56E9Q36520372-D9284042-2D62-458B-920C-A8FA8364CB29Q36634022-38CC1C48-E6F2-4F80-9B7E-98D650EDE835Q36769012-B2BC09D8-239E-43FD-B0E3-CA19FC3249CFQ36813475-33E9462A-31EE-45ED-B1E4-448AF74FBD54Q36944840-04CEF823-CF45-4072-A7B8-22892664FCE8Q37016622-C86D298B-C356-478A-A2E6-894213FA8125Q37116106-A400F7D6-FE7B-4141-8453-FFEFB050A29CQ37155476-B3CF4CE8-F523-4556-8E3B-9905D3A3F53DQ37176590-28E5596A-2615-4DFF-A64E-3B1277F3428FQ37210037-0E1AF673-2EFF-4A1E-B1BC-0990D86E945FQ37215354-9FF65CFE-1E51-4EB7-9479-4841252EEE0EQ37623631-3ED2D387-5E00-48E2-9D21-260A00FC4D02Q37978196-79DFAC85-9EC6-4001-9A33-B41B2DA8E26CQ38004705-A7B53DF6-2043-4475-8784-22498E9EBF23Q38024740-7C5D6D0B-77AD-43B5-A9AF-0C715F286E7BQ38038284-0166B6F5-B32C-479D-B8AC-D2420F0E0B61
P2860
Cytokines mediated inflammation and decreased neurogenesis in animal models of depression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokines mediated inflammatio ...... n animal models of depression.
@en
Cytokines mediated inflammatio ...... n animal models of depression.
@nl
type
label
Cytokines mediated inflammatio ...... n animal models of depression.
@en
Cytokines mediated inflammatio ...... n animal models of depression.
@nl
prefLabel
Cytokines mediated inflammatio ...... n animal models of depression.
@en
Cytokines mediated inflammatio ...... n animal models of depression.
@nl
P1476
Cytokines mediated inflammatio ...... n animal models of depression.
@en
P2093
P304
P356
10.1016/J.PNPBP.2010.06.020
P577
2010-06-30T00:00:00Z